XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program; and various services and support, including technical support services and advanced services. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. It offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.…
XWELL (NASDAQ: XWEL) is listed on Nasdaq, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 175 employees.
The shares were at 0.4100 USD on 20 November 2026, down 53.4% over 52 weeks. Its 52-week range is 0.2600 USD to 2.200 USD: the price is 81.4% below the high and 57.7% above the low.
Its market capitalisation is 4.35M USD.
XWELL reports return on equity of 77.1%, an operating margin of -38.1% and revenue down 7.1% year over year.
It holds more cash than debt, a net cash position of 4.49M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.